DALLAS, TX, Sept. 13, 2021 (GLOBE NEWSWIRE) — by way of NewMediaWire – NaturalShrimp, Inc. (OTCQB: SHMP), a Biotechnology Aquaculture Firm that has developed and patented the primary shrimp-focused, commercially operational RAS (Recirculating Aquaculture System), immediately introduced preliminary trial outcomes of its short-term validation research on the Marineholmen RASLab, in Bergen Norway, to judge the results of hyper-antioxidant applied sciences on oxidation and fish well being in Recirculating Aquaculture Methods (RAS).
The applied sciences being examined create antioxidant environments that cut back the redox response in fish gills and counteract fish susceptibility to the dangerous results of ammonia. NaturalShrimp funded the RASLab analysis via its market improvement partnership with Hydrenesis, Inc., which was the unique commercialization agent for the applied sciences within the aquaculture market. In August 2021, NaturalShrimp acquired the aquaculture belongings of Hydrenesis Aquaculture.
The main target of the research is particularly on freshwater salmon manufacturing and, if confirmed as efficient because the pre-study information has indicated, the applied sciences might allow NaturalShrimp to enter markets together with salmon, barramundi, and different freshwater fish.
“An preliminary trial was carried out with RASLab (Norway) to analyze the results of destructive ORP setting on Atlantic salmon smolt,” mentioned Christine Huynh, DVM aquatic species guide for Pure Shrimp. “Fish grown in Hydrogas had considerably improved welfare scores, fewer inflammatory gill lesions and diminished early maturation. These early outcomes are promising, and our intention is to discover the manufacturing, well being and welfare results additional. The know-how might probably improve the welfare and situation of Atlantic salmon in RAS.”
Marineholmen RASLab’s CEO, Mark Powell, commented, “It appeared from the research we carried out at RASLab that the injection of Hydrogas had no destructive influence on water high quality in RAS or on Atlantic salmon efficiency in recent or brackish saltwater. Furthermore, welfare indicators confirmed that there was a marked enchancment within the exterior fish welfare traits and look of gill well being of fish uncovered to Hydrogas in contrast with management fish. We’re trying ahead to additional exploring the helpful results in follow-up work with Pure Aquatic Methods.”
David Antelo, CEO of Hydrenesis, added, “This trial represents an essential step towards introducing HydroGas know-how into the salmon trade. These preliminary outcomes point out potential purposes not just for salmon, but additionally further species of fin fish. Pure Aquatic Methods and Hydrenesis are centered on increasing these early findings to reveal larger welfare scores and elevated development charges. Validation in these key metrics would open quick paths to licensing EC and Hydrogas applied sciences on a worldwide scale.”
Tom Untermeyer, Chief Know-how Officer and Chief Working Officer of NaturalShrimp, concluded, “We proceed to witness the optimistic results of utilizing the HydroGas know-how for a wide range of aquaculture purposes. The optimistic consequence from this trial additional substantiates our earlier observations. We anticipate that the HydroGas know-how, together with our patented Electrocoagulation (EC) know-how, will present options to many issues which have existed throughout the aquaculture communities.”
About NaturalShrimp
NaturalShrimp, Inc. is a publicly traded aquaculture Firm, headquartered in Dallas, with manufacturing amenities positioned close to San Antonio, Texas and Webster Metropolis, Iowa. The Firm has developed the primary commercially viable system for rising shrimp in enclosed, salt-water methods, utilizing patented know-how to supply recent, by no means frozen, naturally grown shrimp, with out using antibiotics or poisonous chemical compounds. NaturalShrimp methods might be positioned anyplace on this planet to supply gourmet-grade Pacific white shrimp. For extra info go to www.naturalshrimp.com.
Ahead-Trying Statements
This press launch comprises a variety of forward-looking statements that replicate administration’s present views with respect to future occasions and monetary efficiency. Ahead-looking statements are projections in respect of future occasions or our future monetary efficiency. In some instances, you may determine forward-looking statements by terminology similar to “might,” “ought to,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “proceed” or the destructive of those phrases or different comparable terminology. These statements embrace statements relating to the intent, perception or present expectations of us and members of our administration crew, in addition to the assumptions on which such statements are based mostly. Potential buyers are cautioned that any such forward-looking statements aren’t ensures of future efficiency and contain danger and uncertainties, and that precise outcomes might differ materially from these contemplated by such forward-looking statements. These statements are solely predictions and contain recognized and unknown dangers, uncertainties and different components, together with the dangers set forth within the part entitled “Threat Components” within the Firm’s Annual Report on Type 10-Ok for the fiscal yr ended March 31, 2021, any of which can trigger our firm’s or our trade’s precise outcomes, ranges of exercise, efficiency or achievements to be materially completely different from any future outcomes, ranges of exercise, efficiency or achievements expressed or implied in our forward-looking statements.
Investor Relations Contact
Chris Tyson
Govt Vice President
MZ North America
Direct: 949-491-8235
SHMP@mzgroup.us
